Professor Dr. Wong Tin Wui obtained his PhD degree from National University of Singapore in 1999. He is presently the lecturer and research fellow at Universiti Teknologi MARA, Malaysia. His research areas are primarily focused on particle/scaffold design for targeted oral, transdermal and pulmonary drug delivery. His current research interests are innovative use of microwave as skin penetration enhancer for transdermal/topical drug delivery, development of nanoparticle formation processes and design of nanoparticles for diabetes as well as lung, skin and colorectal cancer treatment/prevention. He has authored more than 110 journal and 20 chapter publications in the field of drug delivery.

Prof. Roop Krishen Khar is a renowned academician and a research scientist. He has supervised 72 Ph.D,. 175 M.Pharm. theses and published more than 290 research papers in International & National journals with cumulative impact points of more than 450; H index of 52 , citation of 11673 and i.10 index of 141.. Dr. Khar is inventor of two US & one Indian patent. He has published eleven text books, including the latest one, 4th revised edition (2013) of Lachman/lieberman’s Text Book of Industrial Pharmacy. After superannuation from School of Pharmaceutical Sciences Jamia Hamdard ,presently Prof. Khar is the Principal and professor at B. S. Anangpuria Inst. of Pharmacy Sciences, Faridabad,Haryana.

Tsutomu Yasukawa, MD, is Associate Professor of Ophthalmology and Visual Science at Nagoya City University Graduate School of Medical Sciences in Japan. Dr. Yasukawa is interested in the development of drug delivery systems involving: controlled drug release from implantable devices and microspheres; and drug targeting. Dr. Yasukawa is also interested in the pathogenesis of age-related macular degeneration. Dr. Yasukawa developed a rabbit lipofuscin accumulation model and a 3-dimensional spheroid culture of retinal pigment epithelial cells.

Professor Viness Pillay, a Fulbright Scholar and Fellow of the African Academy of Sciences (AAS), is a South African NRF Research Chair in Pharmaceutical Biomaterials and Polymer-Engineered Drug Delivery Technologies hosted by the University of the Witwatersrand. Prof. Pillay is a Personal Professor of Pharmaceutics and Director of the Wits Advanced Drug Delivery Platform (WADDP) Research Unit at the University of the Witwatersrand, Department of Pharmacy and Pharmacology, South Africa. He has nearly 25 years of experience in the field of drug delivery technology. Prof. Pillay has published more than 220 manuscripts, 47 patents, and over 35 eBooks and book chapters. He is also a Fellow of Academy of Translational Medicine Professionals.

Erem Bilensoy is a full professor of pharmaceutical technology. She graduated from Hacettepe University Faculty of Pharmacy in 1992 and obtained her double Ph.D. degree with “mention tres honorable” with a co-tutelle thesis between Université Paris-Sud and Hacettepe University in 2002 under the supervisions of Dominique Duchene and Atilla Hıncal on the evaluation of amphiphilic ß-cyclodextrins modified on the primary face as novel excipients in the preparation of nanospheres and nanocapsules. She has received full professor position in 2013 from Hacettepe University Faculty of Pharmacy Department of Pharmaceutical Technology. She is the author of more than 70 scientific articles published in SCI indexed journals, 15 international book chapters. She has given more than 30 invited lectures, more than a total of 300 oral and poster presentations receiving more than 1670 citations.

Prof. Carafa is associate Professor of Pharmaceutical Technology – Faculty of Pharmacy and Medicine, University “Sapienza” of Rome. She started her scientific carrier in the development of prolonged/controlled drug delivery systems based on natural polysaccharides. In last years she focused her research on the preparation and the characterization of phospholipid and surfactant vesicles as drug delivery systems for several pharmaceutical applications: topical, ophthalmic, diagnostic, pulmonary, oral, CNSdisorders and cellular targeting.She authored more than 70 journal manuscripts and served as a peer reviewer for about 20 journals in the related field. She is the coauthor of 3 book chapter and 4 patents/patent applications.

Dr. Singh is currently Director of Formulation Development at Acadia Pharmaceuticals Inc. He has over 16 years of extensive R&D experience in pharmaceutical development for NCEs (12 years) and generic drug products (4 years), and approximately 2 years in commercial manufacturing and packaging of solids. Industry experience includes small, mid-size and large pharmaceutical companies and covers both CMC leadership and staff management with increasing responsibilities. His core expertise are in oral solids and sterile powders for infusion, and includes formulation development, process development and scale-up, technology transfer, and regulatory filings for US, Europe and Canada. Previously, Dr. Singh holds a Ph.D in Industrial Pharmacy from St. John’s University, New York, a M.S. in Pharmaceutical Sciences from South Dakota State University, and B. Pharm and M. Pharm degrees from the Indian Institute of Technology (IIT) of Banaras Hindu University in India. He has authored 19 peer-reviewed publications including 3 book chapters, and 5 United States Patents.

Prof. Tania Bresolin is Professor in Quality Assurance at Pharmacy course and Graduate Program in Pharmaceutical Sciences (PPGCF), at University of Vale do Itajaí (UNIVALI), Santa Catarina, Brazil. Her main research interests focus on the Analysis and Quality Control of Drugs and Medicines, HPLC and Analytical Validation, with partnership projects with Company in the development of herbal medicines and phytocosmetics. She is member of CISDEM (Iberoamerican-Swiss Center for Development of Dosage Forms), ABCF (Brazilian Association of Pharmacist), and the Brazilian Pharmacognosy Society.

Dr. Dong Hee Na obtained his BS degree in College of Pharmacy from SungKyunKwan University in 1996 and his Ph.D. degree in Pharmaceutical Sciences from SungKyunKwan University, South Korea in 2001. His professional career includes postdoc at the University of Kentucky College of Pharmacy (2003-2005), assistant/associate professor at College of Pharmacy, Kyungsung University (2005-2012), associate professor at College of Pharmacy, Kyungpook National University (2012-2017), and professor at College of Pharmacy, Chung- Ang University since 2017. He has published more than 100 papers in peer-reviewed journals. Dr. Na’s research focuses on the PEGylation technology for improving pharmaceutical properties of peptide and protein drugs, microparticles engineering for sustained drug delivery, and dendrimer-based nanomedicine technology for targeted drug delivery. Recently, his studies on dendrimer-based nanostructures for inhibiting influenza virus infection and for the treatment of sepsis were published in Nature Nanotechnology (2017;12:48-54) and Biomaterials (2020, article No. 120000). Currently, Dr. Na is an editor of Journal of Pharmaceutical Investigation, the official journal of the Korean Society of Pharmaceutical Sciences and Technology.

Nadia Passerini is Associate Professor of Pharmaceutical Technology at the University of Bologna (Italy). Her research is concerned with the design and manufacture of advanced drug delivery systems, mainly for oral administration. Currently her research interests include the formulation, production and characterization of microparticles obtained by the spray congealing technology, the optimization of granulation and coating processes and the development of pediatric formulations. She is author of over 70 international articles, 2 patents, 1 book chapter and over 50 contributions to national and international conferences.

Dr. Diego Romano Perinelli is a post-doctoral researcher at the School of Pharmacy of the University of Camerino (Italy). He received his Ph.D. in Pharmaceutical Sciences from the University of Camerino in 2015 working on the “physical-chemical characterization of nanostructured drug delivery systems”. He was a visiting researcher in different institutions as Critical Pharmaceuticals (Nottingham, UK), The University of Hong Kong, King’s college of London (UK), University of Lincoln (UK) and University College of Dublin (UCD). Currently, his research is focused on the synthesis and characterization of new biocompatible surfactants and formulation of lipid nanovectors for pharmaceutical applications.

Prof. Dr. Füsun Acartürk is the head of Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Turkey. She has nearly 40 yearsof experience in pharmaceutical technology area. She is an author or co-author of more than 70 original research/review papers in the national/international journals, 8 book chapters and 3 patents. She has supervised MSc and PhDs, 16 postgraduate students. Her current interestlies in electrospinning, nanofibers, 3D printing for drug delivery, colonic and vaginal drug delivery, mucoadhesive drug delivery systems and wound healing.

Dr. Abdul Ahad is an Assistant Professor at Department of Pharmaceutics, College of Pharmacy, King Saud University Riyadh, Saudi Arabia. Dr. Ahad did his Master and Doctorate in Pharmaceutical Sciences from Department of Pharmaceutics, Jamia Hamdard, New Delhi, India. He has published various high quality research and review articles in several peer-reviewed journals of international repute. He is on Editorial Board of several Pharmaceutical journals and reviewer of many peer-reviewed journals. His current interest lies in Nanotechnology products for dermal/transdermal drug delivery and lipid based formulations.

Prof. Farhan Jalees Ahmad has 23 years of rich experience in Research and Teaching. He is working in the area of Nanomedicine for the last 12 years and has published a number of research papers in peer-reviewed journals.He has been granted projects to a tune of rupees 4.5 crores from National agencies like DBT, CCRUM, AYUSH, UGC, DST and International agencies like FIP and OPCW etc. He has earned many accolades including Young Scientist Fast Track from DST, Scientist of the Year-2005 from NESA, UGC Research Award’2011, Bharat Jyoti Award 2011 . He has a US patent, Two PCT and 24 Indian patents to his name. He has published more than 300 research and review papers, 12 Book chapters,9 books. He has guided around 35 M.Pharm students and about 33 PhD scholars.

Prof. Gian Maria Bonora was born in Udine (Italy) in 1944. He obtained a degree in Chemistry from the University of Padova (Italy) in 1969. He was first Associate Professor in the University of Padova (Italy) and then Full Professor of Organic Chemistry in the Universities of Cagliari (Italy) and Trieste (Italy), where actually he is Visiting Professor after his retirement in 2011. He has published more than 280 scientific publications and is a named inventor of 8 issued patents.

Dr. Jia-You Fang is a Professor in the Graduate Institute of Natural Products at Chang Gung University in Taiwan. In addition, he is an Adjunct Professor in the Graduate Institute of Health Industrial Technology, Chang Gung University of Science and Technology and Department of Anesthesiology, Chang Gung Memorial Hospital. Over the past 25 years, he and his team have made outstanding contributions to the understanding of drug delivery, pharmaceutics, pharmacokinetics, nanomedicine, and cosmetology. His contributions add up to 228 peer-review articles, more than 5064 citations and H index of 39 (Scopus).

Dr. Gemeinhart is Associate Professor in the departments of Bioengineering, Chemical Engineering, Biopharmaceutical Sciences, and Ophthalmology and Visual Sciences at the University of Illinois at Chicago. Dr. Gemeinhart is also Research Integrity Officer for the University of Illinois at Chicago. Dr. Gemeinhart was trained in bioengineering (B.S.E. from Purdue University), pharmaceutical sciences (Ph.D. from Purdue University), and chemical engineering (postdoctoral training at Cornell University). In his 20+ years of research, Dr. Gemeinhart has focused on soft mater engineering, with specific applications in biomedical sciences. Dr. Gemeinhart focuses on understanding soft mater and how soft mater can be manipulated (engineered) to control the action of cells through direct material-cell interactions or through delivery of therapeutic molecules. Dr. Gemeinhart has authored more than 50 peer-reviewed publications, 4 book chapters, and 3 patents in the areas of drug delivery and cell-material interactions.

Dr. Gaurav Gupta is the Associate Professor in Department of Pharmacology, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, India has a teaching and research experience of around 7 years. He has an extensive experience in molecular, biochemical and pharmacology with special emphasis on preclinical studies including behavioral, neuropharmacological, nephrological, endocrinological study. To substance above claim he has more than 70 research and review articles in the national and international journals of repute with the total cumulative Impact Factor above 90. He has supervised PhDs, 20 postgraduate students.

Dr. Gupta is a Senior Scientist at Formulation & Drug Delivery Division, CSIR-Indian Institute of Integrative Medicine, Jammu. Dr. Gupta graduated in Pharmacy and obtained his Ph.D. in Pharmaceutical Sciences from the Department of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar (M.P.) India. He did postdoctoral research work in Drug Delivery & Biomaterial Research Group, School of Pharmacy, Queen's University of Belfast, UK with the prestigious fellowship from Bill & Melinda Gates foundation, USA & Wellcome trust, UK. He is recipient of most coveted Young Scholar Award by Ranbaxy Science Foundation in 2007. He has to his credit a good number of publications in international journal of repute. Dr. Gupta is a member of many professional bodies and reviewer for various prestigious journals.

Dr. Clare Hoskins is a Senior Lecturer in Pharmaceutics within the School of Pharmacy at Keele University. She completed her PhD in Pharmaceutics at Robert Gordon University in Aberdeen and subsequently her postdoc at the University of Dundee. Dr Hoskins has over ten years of experience in nanomedicine development and has published over thirty peer-reviewed papers. Dr Hoskins leads Keele Nanopharmaceutics (a vibrant research group whose cutting-edge work in nanomedicine is challenging traditional approaches and pushing past the current boundaries in cancer diagnosis and treatment).

Dr. Philip Chi Lip Kwok obtained his Ph.D. degree in 2007 from The University of Sydney, Australia. Presently, Dr. Kwok is Lecturer of Pharmaceutical Sciences, in the Faculty of Pharmacy, at The University of Sydney. His research mainly focuses on drug delivery to the lungs as aerosols to treat local or systemic diseases. Dr. Kwok has published over 55 manuscripts in various journals of international repute, and his documents have received citations greater than 1,035.

Assistant professor at Faculty of Pharmacy and Medicine, Department of Drug Chemistry and Technologies, “Sapienza” University of Rome. Her research activity is mainly focused on of Pharmaceutical Technology and in particular on: preparation and characterization of phospholipid (liposomes) and non-phospholipid (niosomes) vesicular systems, nanobubbles and nanoemulsions and on their application studies for therapeutic, diagnostic and theranostic approaches. Author of about 60 national and international research papers, 3 patents, 3 book chapters and about 60 oral and poster presentations. Referee for about 10 international journals focused on nanotechnology and drug delivery, member of the Editorial Board of the “World Journal of Respirology.

Dr. Misra is Professor of Pharmacy at Faculty of Pharmacy, former Dean, Faculty of Technology & Engineering & Head Department of Pharmacy at The Maharaja Sayajirao University of Baroda. Dr. Misra holds a Ph.D. in Pharmacy from The Maharaja Sayajirao University of Baroda, Gujarat, India. Dr. Misra has more than 37 years especially in research & development of Novel Drug Delivery Systems. Dr. Misra has mentored 42 PhD and 123 Master students. Dr. Misra has 7 books, 40 book chapters and 149 peer reviewed publications in reputed journals. Dr. Misra has filed 28 national and international patents out of which 6 have been granted so far. Dr. Misra is coordinator of TIFAC-CORE in NDDS, PURSE, DST, SBIRI, DBT and Sub-coordinator of ILSPARE, DBT and is advisor to pharmaceutical, biotechnology and food and cosmetics industries.

Amirhossein Sahebkar received his Pharm.D and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad, Iran), and is currently serving as a faculty member at the Department of Medical Biotechnology (School of Medicine), and Biotechnology Research Center of MUMS, with an adjunct title at the Metabolic Research Centre, University of Western Australia (Perth, Australia). His research focuses on the investigation of novel lipid-modifying agents, including natural products and curcumin, for the management of severe dyslipidemias and atherosclerotic cardiovascular disease.

Dr. H. K. Sharma is a faculty in Pharmaceutics in the Department of Pharmaceutical Sciences, Dibrugarh University, India. He has nearly 20 years of research and teaching experience. His research area includes Drug delivery systems, Natural Pharmaceuticals, and Traditional medicines. He has more than 40 manuscripts, 2 co-authored and 1 co-edited books to his credit. He is associated with several journals as Editorial Board Member and as reviewer. He is also member of various organizations like Indian Pharmaceutical Association, Indian Science Congress Association, American Chemical Society, International Congress for Chemistry & Environment, Association of Pharmaceutical Teachers of India etc.

Dr. Thombre is Research Fellow in Pfizer Inc. He is responsible for the design and development of immediate release and modified release formulations for exploratory and advanced drug candidates, scale-up/technology transfer of manufacturing processes to production, and product enhancement/life cycle management strategies. He is also responsible for the assessment of external drug delivery technologies. Dr. Thombre is a chemical engineer with a Ph.D. from University of Kansas. Dr. Thombre has 31 years’ experience in the pharmaceutical industry and has authored or co-authored more than 55 abstracts, book chapters, and peer-reviewed research articles, 35 oral presentations, and 20 published patent applications. He is a member of the American Association of Pharmaceutical Scientists, Controlled Release Society, and American Institute of Chemical Engineers.

Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.

Dr. Fahima Dilnawaz is working as Women Scientist in the Laboratory of Nanomedicine at Institute of Life Sciences, Bhubaneswar, Odisha, India. She has been actively working with polymeric nanoparticle, magnetic nanoparticle and mesoporous silica nanoparticles based drug delivery system for the cancer therapy. Her current focus is towards theranostic approach of an effective management of cancer. To her credit, she has published several articles and contributed chapters in books. She is also serving as reviewer for various nanomedicinal journals.

Graduated in Physical Education from Universidade Luterana do Brasil-ULBRA. Post-graduation in Exercise Physiology and Training Prescription by Gama Filho University of Rio de Janeiro. Master and PhD in Biological Sciences - Biochemistry by Federal University of Rio Grande do Sul-UFRGS. Currently is linked to the National Postdoctoral Program of CAPES (PNPD / CAPES) and collaborator of the Department of Biochemistry of UFRGS. As a researcher, has experience with several experimental models, including rodents, cell culture and clinical studies. Current research projects focus on the investigation of neuronal dysfunctions associated with inflammatory processes. Immuno-neutralization of proteins, pharmacological agents, diets and physical exercise are some of the methods used as therapeutic alternatives to treat neuropathologies that the inflammation is involved.

Dr. M Saquib Hasnain has over 6 years of research experience in the field of drug delivery and pharmaceutical formulation analyses, especially systematic development and characterization of diverse nanostructured drug delivery systems, controlled release drug delivery systems, bioenhanced drug delivery systems, nanomaterials and nanocomposites employing Quality by Design approaches as well as development and characterization of polymeric composites, formulation characterization using FTIR, DSC, PXRD, SEM, TEM, HPLC, LC-MS, and many more. Till date he has authored over 30 publications in various high impact peer-reviewed journals, 30 book chapters, and 1 book. He is also serving as the reviewer of several prestigious journals.

Dr. Raza is an Assistant Professor of Biotechnology, and In-charge of the Department of Stem Cell Biology and Regenerative Medicine at Era’s Lucknow Medical College and Hospital (ELMC&H), Era University, Lucknow. He is a Visiting Scientist at American University of Barbados, Latin America since, 2015. His laboratory’s interest lies in elucidating the ways to how best to utilize stem cell therapy to treat neurodegenerative diseases. His lab strives to understand the survival and death cues for stem cells in oxidative and/or inflammatory microenvironment. Further, his lab is interested in the development of new therapeutic approaches such as nanoparticles-mediated delivery and protein therapy for stem cells, and delivery of nanoparticles tagged stem cells into the rodent models of stroke, spinal cord injury and Alzheimer’s disease.

Dr Touraj Ehtezazi is working as Senior Lecturer, at School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University. His h-index is 10 with peer-reviewed papers in the field of drug delivery systems. His research interest includes pharmaceutical inhalers, 3D printing, and brain targeting drug delivery systems. Touraj has supervised 3 PhD students, and currently is also supervising other 3 PhD students. Dr Ehtezazi has joined Young onset dementia group at The Walton Centre (Neurology and Neurosurgery), Liverpool since 2018. He is working on the neurotoxicity of hydrophobic bile acids in Alzheimer’s disease, and identifying suitable treatments to prevent/delay Alzheimer’s disease. Touraj also has established collaborations with the Department of Clinical Neurosciences, University of Cambridge for the development of novel brain targeting drug delivery systems for the treatment of multiple sclerosis and ischemic stroke. He has published a paper with this group and more papers are in the pipeline. Dr Ehtezazi was awarded a grant by The Royal Society of Chemistry in developing 3D printed light-activated wound dressings. Also, Dr Ehtezazi was awarded a grant by the Liverpool John Moores University to develop protocols to minimise aerosol levels in dental clinics to minimise contraction of COVID-19 for both clinical staff and patients. Touraj also is leader of drug delivery formulation section in Centre for Natural Product Discovery at Liverpool John Moores University.

Dr. A. K. Tiwary is working as Professor (Pharmaceutics) in the Department of Pharmaceutical Sciences & Drug Research at Punjabi University, Patiala, India. He completed his PhD in Pharmaceutics at Birla Institute of Technology, Mesra, Ranchi, India. He has to his credit 113 research papers/articles and one US Patent. His h- index is 30 and i-10 index is 66. He has guided 12 PhD scholars and more than 45 M. Pharm. students. His research pursuits include transdermal drug delivery, modified oral drug delivery using natural polymers and their derivatives, spermicidals, microemulsions and SMEDDS. He actively contributes his expertise to industries, academia and is on the board of many reputed journals as reviewer and editorial board advisor.